Research map: Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials

Back to the article

Papers in this map

  1. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study · Karen N Barnett · 2012 · 7221 citations · Cited by this paper
  2. Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure · 2025 · Related
  3. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer · Leora Horn · 2018 · 3642 citations · Cited by this paper
  4. Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas · 2025 · Related
  5. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial · Luis G Paz-Ares · 2019 · 2314 citations · Cited by this paper
  6. Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma · 2026 · Related
  7. Small cell lung cancer: Where do we go from here? · Lauren A. Byers · 2014 · 651 citations · Cited by this paper
  8. A phase 2 prospective trial of re-irradiation of locally recurrent or second primary head and neck tumors using stereotactic body radiation therapy · 2025 · Related
  9. Performance of Two Geriatric Screening Tools in Older Patients With Cancer · Cindy Kenis · 2013 · 395 citations · Cited by this paper
  10. Unraveling the microbiome’s role in breast cancer progression and treatment response · 2025 · Related
  11. Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy · Giannis Mountzios · 2025 · 272 citations · Cited by this paper
  12. Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database · 2026 · Related
  13. Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer · Soo Han Kim · 2023 · 29 citations · Cited by this paper
  14. Immune-metabolic plasticity in AML: Prognostic roles of aCTLs (activated Cytotoxic T Cells) and Kynurenine · 2026 · Related
  15. Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility · Daichi Fujimoto · 2023 · 27 citations · Cited by this paper
  16. The current state of proton radiotherapy · 2024 · Related
  17. Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients · Toshio Kubo · 2020 · 21 citations · Cited by this paper
  18. Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis · 2025 · Related
  19. Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis · Jiayi Gao · 2023 · 17 citations · Cited by this paper
  20. Clinical characteristics and treatment analysis of pulmonary blastoma (PB): a report of 17 cases · 2025 · Related
  21. Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer · Rebekah Rittberg · 2022 · 16 citations · Cited by this paper
  22. Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study · Takayuki Takeda · 2023 · 15 citations · Cited by this paper
  23. Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer · J.W. Shaw · 2024 · 15 citations · Cited by this paper
  24. The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study · Myeong Geun Choi · 2023 · 13 citations · Cited by this paper
  25. Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study · Kazuhito Misawa · 2024 · 10 citations · Cited by this paper
  26. Real-world treatment patterns and survival in extensive stage small-cell lung cancer in Japan · Hidehito Horinouchi · 2024 · 6 citations · Cited by this paper
  27. Âge et décision de prise en charge des patients atteints d’un cancer pulmonaire primitif · S. Yonnet · 2008 · 5 citations · Cited by this paper
  28. Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system · Yifeng Bai · 2024 · 5 citations · Cited by this paper
  29. Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer · Satoshi Ano · 2024 · 4 citations · Cited by this paper
  30. Prospective nutritional status and body mass composition assessment in patients with advanced NSCLC treated with immune checkpoint inhibitors. · Federica Pecci · 2024 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)